Application and Progress of Antibody-Drug Conjugates (ADCs) in the Treatment of Metastatic Triple-Negative Breast Cancer.
The publication reviews therapeutic advances in metastatic triple-negative breast cancer (TNBC), highlighting the limite...
Correction to “Cancer treatment and survivorship statistics, 2025”.
- Post category:Breast Cancer
- Reading time:1 min read
The publication with DOI 10.3322/caac.70036 is titled "Cancer statistics, 2020" by Siegel RL, Miller KD, Jemal A. It pro...
How ACCURE Closed Racial Survival Gaps in Cancer — And How CMS PIN Codes Scale It
- Post category:Breast Cancer/Pan Cancer/Respiratory (Lung, Bronchus) System/Supportive Oncology
- Reading time:4 mins read
You’ve seen the survival gaps. You’ve felt the impact. And the question that follows is both urgent and fair:What exactly can you do about it — in your clinic, with…
The Immunotherapy Clock Has Moved
- Post category:Breast Cancer/Genitourinary (Prostate, Bladder) System/Head & Neck Cancers/Pan Cancer/Respiratory (Lung, Bronchus) System/Supportive Oncology/Survivorship
- Reading time:3 mins read
Checkpoint inhibitors are no longer reserved for late-stage salvage. The clearest signal from recent meetings and trials is this: the greatest survival benefit may be increasingly found in neoadjuvant and perioperative settings. This…